Madrigal Pharmaceuticals, Inc. (LON:0JXI)

Madrigal Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	198.69	100.02	99.92	331.55	36.27
Short-Term Investments	784.87	826.23	534.22	27.23	234.08
Cash & Short-Term Investments	983.56	926.25	634.13	358.77	270.35
Cash Growth	6.19%	46.07%	76.75%	32.71%	-4.86%
Accounts Receivable	134.48	53.82	-	-	-
Inventory	74.84	34.07	-	-	-
Other Current Assets	52.89	18.79	3.15	2.6	1.34
Total Current Assets	1,246	1,033	637.28	361.37	271.68
Net Property, Plant & Equipment	6.44	4.59	3.27	1.2	1.65
Other Intangible Assets	7.38	4.73	-	-	-
Total Assets	1,260	1,042	640.55	362.57	273.33
Accounts Payable	48.88	43.6	28.04	23.83	21.38
Accrued Expenses	260.39	124.7	89.98	91.46	55.05
Current Portion of Leases	1.02	0.98	0.53	0.6	0.41
Total Current Liabilities	310.29	169.28	118.55	115.89	76.84
Long-Term Debt	339.88	117.57	115.48	49.29	-
Long-Term Leases	6.73	1.02	1.19	-	0.39
Total Long-Term Liabilities	346.61	118.59	116.67	49.29	0.39
Total Liabilities	656.9	287.86	235.21	165.18	77.23
Common Stock	0	0	0	0	0
Additional Paid-in Capital	2,692	2,556	1,741	1,160	863.5
Accumulated Other Comprehensive Income	0.87	0.47	0.47	-0.03	-0.08
Retained Earnings	-2,090	-1,802	-1,336	-962.66	-667.31
Shareholders' Equity	602.69	754.38	405.33	197.39	196.11
Total Liabilities & Equity	1,260	1,042	640.55	362.57	273.33
Total Debt	347.63	119.57	117.19	49.89	0.8
Net Cash (Debt)	635.93	806.68	516.94	308.88	269.55
Net Cash Growth	-21.17%	56.05%	67.36%	14.59%	-4.88%
Net Cash Per Share	28.35	37.92	27.66	18.02	16.30
Book Value	602.69	754.38	405.33	197.39	196.11
Book Value Per Share	26.86	35.46	21.69	11.52	11.86
Tangible Book Value	595.31	749.65	405.33	197.39	196.11
Tangible Book Value Per Share	26.54	35.24	21.69	11.52	11.86

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.